Synergistic inhibition of enterovirus 71 replication by interferon and rupintrivir

Journal of Infectious Diseases

Volumn 203, Issue 12, 2011, Pages 1784-1790

  Hung, Hui Chen ^a   Wang, Hsiang Ching ^b,e   Shih, Shin Ru ^a,b,c   Teng, I Fang ^a   Tseng, Ching Ping ^d   Hsu, John T A ^a,d  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^e INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 9; INTERFERON STIMULATED GENE FACTOR 3; JANUS KINASE 1; PROTEIN KINASE R; PROTEINASE; RUPINTRIVIR; STAT2 PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL ASSAY; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; ENTEROVIRUS 71; ENZYME ASSAY; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SIGNAL TRANSDUCTION; VERO CELL; VIRUS CELL INTERACTION; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

ALGORITHMS; ANIMALS; ANTIVIRAL AGENTS; BLOTTING, WESTERN; CERCOPITHECUS AETHIOPS; DNA PRIMERS; DOWN-REGULATION; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ENTEROVIRUS A, HUMAN; ENTEROVIRUS INFECTIONS; HUMANS; INTERFERON-ALPHA; INTERFERON-STIMULATED GENE FACTOR 3, GAMMA SUBUNIT; ISOXAZOLES; POLYMERASE CHAIN REACTION; PYRROLIDINONES; RECOMBINANT PROTEINS; RHABDOMYOSARCOMA; TUMOR CELLS, CULTURED; VERO CELLS; VIRUS REPLICATION;

EID: 79957501648     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir174     Document Type: Article

References (29)

1. Bowie AG, Unterholzner L. Viral evasion and subversion of pattern-recognition receptor signalling. Nat Rev Immunol 2008; 8:911-22.
2. Li K, Foy E, Ferreon JC, et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A 2005; 102:2992-7. (Pubitemid 40299904)
3. Yang Y, Liang Y, Qu L, et al. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc Natl Acad Sci U S A 2007; 104:7253-8. (Pubitemid 47186041)
4. Barral PM, Sarkar D, Fisher PB, Racaniello VR. RIG-I is cleaved during picornavirus infection. Virology 2009; 391:171-6.
5. Pallansch MA, Roos R. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In: Knipe DM, ed. Fields Virology. Philadelphia: Wolters Kluwer Lippincott Williams &Wilkins, 2007: 839-93.
6. Ho M. Enterovirus 71: the virus, its infections and outbreaks. J Microbiol Immunol Infect 2000; 33:205-16. (Pubitemid 32046397)
7. Weng KF, Li ML, Hung CT, Shih SR. Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation. PLoS Pathog 2009; 5:e1000593.
8. Badorff C, Lee GH, Lamphear BJ, et al. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 1999; 5:320-6. (Pubitemid 29124369)
9. Badorff C, Berkely N, Mehrotra S, Talhouk JW, Rhoads RE, Knowlton KU. Enteroviral protease 2A directly cleaves dystrophin and is inhibited by a dystrophin-based substrate analogue. J Biol Chem 2000; 275:11191-7. (Pubitemid 30212763)
10. Shih SR, Stollar V, Lin JY, Chang SC, Chen GW, Li ML. Identification of genes involved in the host response to enterovirus 71 infection. J Neurovirol 2004; 10:293-304. (Pubitemid 39429940)
11. Morrison JM, Racaniello VR. Proteinase 2Apro is essential for enterovirus replication in type I interferon-treated cells. J Virol 2009; 83:4412-22.
12. Lei X, Liu X, Ma Y, et al. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J Virol 2010; 84:8051-61.
13. Kuo CJ, Shie JJ, Fang JM, et al. Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents. Bioorg Med Chem 2008; 16:7388-98.
14. Lin TY, Chang LY, Hsia SH, et al. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis 2002; 34(Suppl 2):S52-7.
15. Lee JC, Shih SR, Chang TY, et al. A mammalian cell-based reverse two-hybrid system for functional analysis of 3C viral protease of human enterovirus 71. Anal Biochem 2008; 375:115-23.
16. Shih SR, Chiang C, Chen TC, et al. Mutations at KFRDI and VGK domains of enterovirus 71 3C protease affect its RNA binding and proteolytic activities. J Biomed Sci 2004; 11:239-48. (Pubitemid 38269814)
17. Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984; 22:27-55.
18. Harada H, Matsumoto M, Sato M, et al. Regulation of IFN-alpha/beta genes: evidence for a dual function of the transcription factor complex ISGF3 in the production and action of IFN-alpha/beta. Genes Cells 1996; 1:995-1005. (Pubitemid 126670804)
19. Blom N, Hansen J, Blaas D, Brunak S. Cleavage site analysis in picornaviral polyproteins: discovering cellular targets by neural networks. Protein Sci 1996; 5:2203-16. (Pubitemid 26384459)
20. Black TL, Safer B, Hovanessian A, Katze MG. The cellular 68,000-Mr protein kinase is highly autophosphorylated and activated yet significantly degraded during poliovirus infection: implications for translational regulation. J Virol 1989; 63:2244-51. (Pubitemid 19107821)
21. Chou TC, Talaly P. A simple generalized equation for the analysis of multiple inhibitions of Michaelis-Menten kinetic systems. J Biol Chem 1977; 252:6438-2.
22. Loo YM, Gale M Jr.. Viral regulation and evasion of the host response. Curr Top Microbiol Immunol 2007; 316:295-313.
23. Randall RE, Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 2008; 89:1-47.
24. Hung HC, Chen TC, Fang MY, et al. Inhibition of enterovirus 71 replication and the viral 3D polymerase by aurintricarboxylic acid. J Antimicrob Chemother 2010; 65:676-83.
25. Li ML, Hsu TA, Chen TC, et al. The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology 2002; 293:386-95.
26. Papon L, Oteiza A, Imaizumi T, et al. The viral RNA recognition sensor RIG-I is degraded during encephalomyocarditis virus (EMCV) infection. Virology 2009; 393:311-8.
27. Johnson VA, Merrill DP, Chou TC, Hirsch MS. Human immunodeficiency virus type 1 (HIV-1) inhibitory interactions between protease inhibitor Ro 31-8959 and zidovudine, 2′,3′-dideoxycytidine, or recombinant interferon-alpha A against zidovudine-sensitive or -resistant HIV-1 in vitro. J Infect Dis 1992; 166:1143-6.
28. Lin K, Kwong AD, Lin C. Combination of a hepatitis C virus NS3-NS4A protease inhibitor and alpha interferon synergistically inhibits viral RNA replication and facilitates viral RNA clearance in replicon cells. Antimicrob Agents Chemother 2004; 48:4784-92. (Pubitemid 39577685)
29. Patick AK, Binford SL, Brothers MA, et al. In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease. Antimicrob Agents Chemother 1999; 43:2444-50.